Health

TraceLink Customers Demonstrate Readiness as DSCSA Dispenser Deadline Arrives

TraceLink Continues to Set the Standard for United States Drug Supply Chain Security (DSCSA) Leadership, Proven by Real-World Success, Industry…

2 weeks ago

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses – - A novel mechanism…

2 weeks ago

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF

EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative…

2 weeks ago

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025

Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety data from Phase 1 on…

2 weeks ago

ICP DAS-BMP Attends MOU Signing Ceremony to Mark a New Milestone in Medical-Grade TPU Materials

HSINCHU, Nov. 9, 2025 /PRNewswire/ -- ICP DAS-BMP participated in the Strategic Memorandum of Understanding (MOU) signing ceremony organized by…

2 weeks ago

NCCN Celebrates Expanding Access to Cancer Treatment in Africa at 2025 AORTIC Meeting with New NCCN Adaptations for Sub-Saharan Africa

Updated cancer treatment guidelines reflect significant progress in cancer care delivery through ongoing collaborative efforts to strengthen oncology resources across…

2 weeks ago

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

November 08, 2025 17:13 ET  | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…

2 weeks ago

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical…

2 weeks ago

The 5th World Health Forum Highlights Climate Change as a Defining Public Health Challenge

BEIJING, Nov. 4, 2025 /PRNewswire/ -- The 5th World Health Forum convened in Beijing on November 1, gathering nearly 400…

2 weeks ago

Healthcare Holding Schweiz Acquires a Stake in QUNIQUE

Healthcare Holding Schweiz AG, a leading provider of medical technology services and distribution solutions in Switzerland, has expanded its portfolio…

2 weeks ago